BR0312197A - Polissacarìdeo supersulfatado de baixo peso molecular - Google Patents

Polissacarìdeo supersulfatado de baixo peso molecular

Info

Publication number
BR0312197A
BR0312197A BR0312197-6A BR0312197A BR0312197A BR 0312197 A BR0312197 A BR 0312197A BR 0312197 A BR0312197 A BR 0312197A BR 0312197 A BR0312197 A BR 0312197A
Authority
BR
Brazil
Prior art keywords
epik5
molecular weight
low molecular
supersulfated
polysaccharide
Prior art date
Application number
BR0312197-6A
Other languages
English (en)
Inventor
Pasqua Anna Oreste
Giorgio Zoppetti
Original Assignee
Glycores 2000 Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2002MI001346A external-priority patent/ITMI20021346A1/it
Priority claimed from IT2002MI001345A external-priority patent/ITMI20021345A1/it
Priority claimed from ITMI20021854 external-priority patent/ITMI20021854A1/it
Application filed by Glycores 2000 Srl filed Critical Glycores 2000 Srl
Publication of BR0312197A publication Critical patent/BR0312197A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products

Abstract

'POLISSACARìDEO SUPERSULFATADO DE BAIXO PESO MOLECULAR". K5-N, O-supersulfatos de BPM são descritos, tendo um grau de sulfatação de 3,2 a 4 e um peso molecular médio de cerca de 3.000 a cerca de 6.000, obtenível por despolimerização de correspondentes K5-N, O-supersulfatos ou partindo de K5-N-sulfatos de BPM por O-supersulfatação de um sal de amina terciária ou de amónio quaternário do mesmo e subsequente N-re-sulfatação do K5-amina-O-supersulfato assim obtido. Além do mais, composições farmacêuticas contendo estes K5-N, O-supersulfatos de BPM tendo uma atividade antiangiogênica e antiviral, em particular anti-HIV-1. K5-N-sulfatos intermediários também são descritos.
BR0312197-6A 2002-06-18 2003-06-17 Polissacarìdeo supersulfatado de baixo peso molecular BR0312197A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT2002MI001346A ITMI20021346A1 (it) 2002-06-18 2002-06-18 Polisaccaridi a basso peso molecolare e procedimento per la loro preparazione
IT2002MI001345A ITMI20021345A1 (it) 2002-06-18 2002-06-18 Derivati epimerizzati del polissacaride k5 a elevatissimo grado di solfatazione
ITMI20021854 ITMI20021854A1 (it) 2002-08-27 2002-08-27 Polisaccaride supersolfatato a basso peso molecolare.
PCT/IB2003/002347 WO2003106506A1 (en) 2002-06-18 2003-06-17 Low molecular weight oversulfated polysaccharide

Publications (1)

Publication Number Publication Date
BR0312197A true BR0312197A (pt) 2005-04-05

Family

ID=29740492

Family Applications (3)

Application Number Title Priority Date Filing Date
BR0312197-6A BR0312197A (pt) 2002-06-18 2003-06-17 Polissacarìdeo supersulfatado de baixo peso molecular
BR0312179-8A BR0312179A (pt) 2002-06-18 2003-06-17 Processo para preparação de derivado de epik5-n-o-supersulfato, composição farmacêutica e composição cosmética contendo o mesmo e seu uso
BR0312182-8A BR0312182A (pt) 2002-06-18 2003-06-17 Derivados de n-acil-(epi)k5-amina-o-supersulfato, processo para sua preparação, composição farmacêutica e cosmética contendo os mesmos

Family Applications After (2)

Application Number Title Priority Date Filing Date
BR0312179-8A BR0312179A (pt) 2002-06-18 2003-06-17 Processo para preparação de derivado de epik5-n-o-supersulfato, composição farmacêutica e composição cosmética contendo o mesmo e seu uso
BR0312182-8A BR0312182A (pt) 2002-06-18 2003-06-17 Derivados de n-acil-(epi)k5-amina-o-supersulfato, processo para sua preparação, composição farmacêutica e cosmética contendo os mesmos

Country Status (15)

Country Link
US (4) US7838644B2 (pt)
EP (3) EP1517924A1 (pt)
JP (3) JP2005536577A (pt)
CN (3) CN1671744A (pt)
AT (1) ATE485308T1 (pt)
AU (3) AU2003240190B2 (pt)
BR (3) BR0312197A (pt)
CA (3) CA2489870A1 (pt)
DE (1) DE60334617D1 (pt)
IL (2) IL165808A0 (pt)
MX (3) MXPA04012805A (pt)
NO (3) NO20050245L (pt)
NZ (3) NZ537217A (pt)
PL (3) PL373004A1 (pt)
WO (3) WO2003106506A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20032498A1 (it) * 2003-12-17 2005-06-18 Pasqua Anna Oreste Polisaccaridi antitrombotici a basso peso molecolare e
ITMI20010397A1 (it) * 2001-02-27 2002-08-27 Giorgio Zoppetti Derivati altamente n,o-solfatati del polisaccaride k5 e loro preparazione
US8513407B2 (en) * 2002-06-18 2013-08-20 Glycores 2000 S.R.L. Process for the preparation of N-acyl-(epi)K5-amine-O-sulfate-derivatives and products thus obtained
US20120253029A1 (en) 2002-06-18 2012-10-04 Pasqua Anna Oreste Process for the preparation of highly o-sulfated epimerized derivatives of k5 polysaccharide and intermediates therein
JP2005536577A (ja) * 2002-06-18 2005-12-02 グリコレス ２０００ ソシエタ ア レスポンサビリタ リミタータ Ｎ−アシル−（エピ）ｋ５−アミン−ｏ−硫酸塩誘導体の製造方法およびｎ−アシル−（エピ）ｋ５−アミン−ｏ−硫酸塩誘導体
ITMI20031618A1 (it) * 2003-08-06 2005-02-07 Inalco Spa Derivati polisaccaridici dotati di alta attivita'
FR2871476B1 (fr) * 2004-06-14 2011-04-01 Ifremer Derives depolymerises sulfates d'exopolysaccharides (eps) provenant de bacteries marines mesophiles, leur procede de preparation et leurs utilisations en regeneration tissulaire
FR2871379B1 (fr) 2004-06-14 2006-09-29 Ifremer Utilisation de derives polysaccharidiques hautement sulfates et de faible masse molaire pour moduler l'angiogenese
US8318973B2 (en) * 2005-10-21 2012-11-27 Bezwada Biomedical, Llc Functionalized sinapic acid and methyl sinapate

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1141483B (it) * 1980-04-18 1986-10-01 Crinos Industria Farmaco Resina poliamminica per la separazione selettiva di eparina da altri glucosamminoglicani e procedimento per la sua preparazione
FR2503714B1 (fr) * 1981-04-10 1986-11-21 Choay Sa Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine
EP0245813B2 (en) * 1986-05-16 2000-03-22 ITALFARMACO S.p.A. EDTA-free heparins, heparin fractions and fragments, processes for their preparation and pharmaceutical compositions containing them
EP0333243A3 (en) * 1988-03-10 1989-09-27 Akzo N.V. Sulphated k5 antigen and sulphated k5 antigen fragments
FR2669932B1 (fr) * 1990-12-03 1994-07-01 Sanofi Sa Nouvel heparosane-n,o-sulfate, son procede de preparation et les compositions pharmaceutiques qui le contiennent.
GB2254083A (en) 1991-03-28 1992-09-30 Italfarmaco Spa Anticoagulants from e.coli saccharide
FR2684385B1 (fr) * 1991-11-28 1997-08-01 Sanofi Elf Heparosanes-n,o-sulfates de haute masse moleculaire, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
IT1271057B (it) * 1994-11-04 1997-05-26 Inalco Spa Polisaccaridi aventi un elevato contenuto di acido iduronico
US5798356A (en) * 1995-08-07 1998-08-25 Alcon Laboratories, Inc. Angiostatic compounds
IT1282994B1 (it) 1996-05-10 1998-04-03 Inalco Spa Derivati del polisaccaride k5 aventi elevata attivita' anticoagulante
IT1284143B1 (it) * 1996-09-06 1998-05-08 Istituto Scient Di Chimica E B Eparansolfati semi-sintetici ad elevata attivita' antimetastica e ridotto rischio emorragico
GB9620459D0 (en) 1996-10-01 1996-11-20 Mclaughlin Andrew Improvements in or relating to blocked isocyanates and their production
IT1289613B1 (it) * 1997-02-07 1998-10-15 Inalco Spa Polisaccaridi batterici o-solfatati
IT1290814B1 (it) * 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
US6329351B1 (en) * 1997-08-28 2001-12-11 Istituto Scientifico Di Chimica E Biochimica “G. Ronzoni” Semi-synthetic sulphaminoheparosansulphates having high anti-metastatic activity and reduced haemorrhagic risk
US6388060B1 (en) * 1998-11-06 2002-05-14 Vascular Therapeutics Inc. Process for the sulfation of uronic acid-containing polysaccharides
US20020062019A1 (en) * 2000-03-30 2002-05-23 Pasqua Oreste Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
IT1318432B1 (it) * 2000-03-30 2003-08-25 Inalco Spa Glicosaminoglicani derivati dal polisaccaride k5 aventi elevataattivita' anticoagulante ed antitrombotica e processo per la loro
US20050027117A1 (en) * 2000-12-18 2005-02-03 Pasqua Oreste Anticoagulant and antithrombotic LMW-glycosaminoglycans derived from K5 polysaccharide and process for their preparation
ITMI20032498A1 (it) * 2003-12-17 2005-06-18 Pasqua Anna Oreste Polisaccaridi antitrombotici a basso peso molecolare e
ITMI20010397A1 (it) * 2001-02-27 2002-08-27 Giorgio Zoppetti Derivati altamente n,o-solfatati del polisaccaride k5 e loro preparazione
ITMI20010779A1 (it) * 2001-04-12 2002-10-12 Giorgio Zoppetti Uso di polisaccaridi batterici solfati atti all'inibizione dell'angiogenesi
ITMI20011633A1 (it) * 2001-07-27 2003-01-27 San Raffaele Centro Fond Uso di polisaccaridi batterici supersolfatati inibitori dell'hiv
ITMI20012200A1 (it) * 2001-10-22 2003-04-22 Ibsa Inst Biochimique Sa Processo per la preparazione di condroitin solfati dal polisaccaride k4 e prodotti ottenuti
ITMI20021294A1 (it) * 2002-06-12 2003-12-12 Inalco Spa Polisaccaridi batterici o-solfatati e loro uso
JP2005536577A (ja) * 2002-06-18 2005-12-02 グリコレス ２０００ ソシエタ ア レスポンサビリタ リミタータ Ｎ−アシル−（エピ）ｋ５−アミン−ｏ−硫酸塩誘導体の製造方法およびｎ−アシル−（エピ）ｋ５−アミン−ｏ−硫酸塩誘導体
ITMI20032614A1 (it) * 2003-12-30 2005-06-30 Altergon Sa Nuova composizione comprendente cs

Also Published As

Publication number Publication date
US20050245736A1 (en) 2005-11-03
AU2003240191A1 (en) 2003-12-31
JP2005530877A (ja) 2005-10-13
AU2003240190A1 (en) 2003-12-31
NZ537216A (en) 2005-05-27
WO2003106506A1 (en) 2003-12-24
IL165807A0 (en) 2006-01-15
CA2489862C (en) 2012-03-27
EP1513880B1 (en) 2010-10-20
PL373004A1 (en) 2005-08-08
US20060014718A1 (en) 2006-01-19
MXPA04012721A (es) 2005-08-15
JP5053512B2 (ja) 2012-10-17
CA2489866A1 (en) 2003-12-24
CA2489870A1 (en) 2003-12-24
EP1517924A1 (en) 2005-03-30
IL165807A (en) 2011-10-31
JP2005533878A (ja) 2005-11-10
US20050256079A1 (en) 2005-11-17
ATE485308T1 (de) 2010-11-15
PL375088A1 (en) 2005-11-14
NO20050245L (no) 2005-03-16
CN1675250B (zh) 2012-11-14
WO2003106504A1 (en) 2003-12-24
AU2003242881A1 (en) 2003-12-31
PL375087A1 (en) 2005-11-14
NZ537217A (en) 2005-09-30
US20110021766A1 (en) 2011-01-27
IL165808A0 (en) 2006-01-15
EP1513880A1 (en) 2005-03-16
JP2005536577A (ja) 2005-12-02
CN1671744A (zh) 2005-09-21
WO2003106505A1 (en) 2003-12-24
CN1675250A (zh) 2005-09-28
EP1519961A1 (en) 2005-04-06
CN1675249A (zh) 2005-09-28
WO2003106505A9 (en) 2004-02-26
AU2003240190B2 (en) 2009-07-09
US7838644B2 (en) 2010-11-23
NZ537215A (en) 2006-11-30
DE60334617D1 (de) 2010-12-02
BR0312182A (pt) 2005-04-05
CA2489862A1 (en) 2003-12-24
MXPA04012805A (es) 2005-08-19
MXPA04012714A (es) 2005-08-15
NO20050244L (no) 2005-03-16
US8193166B2 (en) 2012-06-05
BR0312179A (pt) 2005-04-05
NO20050247L (no) 2005-03-16

Similar Documents

Publication Publication Date Title
NO20050247L (no) Lavmolekylaert oversulfatert polysakkarid
BRPI0413728A (pt) muteìnas de lipocalina da lágrima
ATE430558T1 (de) Herstellung von mikrokügelchen
BR0308919A (pt) Células-tronco programáveis, desdiferenciadas de origem monocìtica, e sua produção e uso
EA200400878A1 (ru) Новые эфиры флуоренкарбоновых кислот, способ их получения, а также их применение в качестве лекарственных средств
EA200500169A1 (ru) Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение
HK1131167A1 (zh) 淚液脂質運載蛋白的突變蛋白及其獲得方法
WO2005023185A3 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
MA27880A1 (fr) Derives de tetrahydrocarbazole et leur utilisation pharmaceutique
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
BRPI0311700B8 (pt) processo para a produção de uma preparação em forma de película e preparação em forma de película
EA200401111A1 (ru) Биполярные соли транс-каротиноидов и их применение
EA200200096A1 (ru) Новые производные витамина d с циклическими субструктурами в боковых цепях, способ и промежуточные продукты для их получения и их применение для получения лекарственных средств
BRPI0414979A (pt) preparação sólida
ATE315049T1 (de) Hochsulfatierte derivate von k5-polysacchariden und ihre herstellung
AR039186A1 (es) Celulas madre indiferenciadas programables de origen monocitaro, su obtencion y uso
BRPI0408117A (pt) compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos
GB2440089A (en) Regeneration system its production and use
FR2804321B1 (fr) Utilisation de derives de polyaminoacides pour traiter la seborrhee et les desordres cutanes associes
DE60209355D1 (de) Kosmetische zubereitung gegen hautfalten
CY1111290T1 (el) Παραγωγα 9-αλκυλαμινo-1-νιτρoακριδινης
DK1232173T3 (da) Nye fusidinsyrederivater
EA200401358A1 (ru) 2,5-бис-диамин-[1,4]бензохиноновые производные для лечения болезни альцгеймера, способ их получения и промежуточные продукты
BR0313613A (pt) Variantes do principal alérgeno phl p 1 de capim-timóteo

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]